We think this might be relevant to the clinical guidance for Fournier's Gangrene Severity Index (FGSI).
Fournier's Gangrene Severity Index
Fournier's Gangrene Severity Assessment
Vitals & Physiology
°C
bpm
bpm
Laboratory Values
mmol/L
mmol/L
mg/dL
mmol/L
%
10³/µL
Awaiting Values
Complete all 9 physiological and laboratory parameters to calculate the FGSI.
Guidelines & Evidence
Verified
Last Review: 2026
Overview & Clinical Context
Definition & Clinical Utility
Fournier’s gangrene is a rapidly progressive necrotizing fasciitis involving the perineum, genitalia, and perianal regions. The Fournier’s Gangrene Severity Index (FGSI) is a validated prognostic tool used at the time of admission to stratify disease severity and predict mortality risk. It enables clinicians to identify high-risk patients early, guide aggressiveness of management (e.g., ICU admission, early repeat debridement), and inform discussions regarding prognosis.
Why FGSI Matters in Practice
Provides objective mortality prediction at admission
Helps triage patients to ICU vs high-dependency care
Guides urgency and aggressiveness of surgical debridement
Useful for audit, research, and outcome benchmarking
Complements (but does not replace) clinical judgment
Pathophysiology of Fournier’s Gangrene
Fournier’s gangrene is typically polymicrobial, involving aerobic and anaerobic organisms that produce synergistic tissue destruction. Infection spreads along fascial planes (Colles’, Dartos’, Scarpa’s fascia), leading to microvascular thrombosis, ischemia, and rapid necrosis. Systemic toxicity results from sepsis, cytokine storm, and multiorgan dysfunction. FGSI captures this systemic derangement via physiological and laboratory abnormalities.
Related Scores in Practice
In clinical practice, this assessment is frequently evaluated alongside other validated measures. Depending on the patient's presentation and specific diagnostic requirements, you may also need to utilize the Apacheii, Sofa Score, or the Sirs to formulate a comprehensive care plan.
